| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-12 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-11 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-11 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-10 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-08 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-08 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-08 |
| mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-08 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |